Luna Vasconcelos Felippe

Luna Vasconcelos Felippe

Auto-generated profile, based on publicly available information

Luna Vasconcelos Felippe

Health Sciences Center, Federal University of Espirito Santo

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
ACAlejandra Cardenas-Rojas
Alejandra Cardenas-Rojas
LCLuis Castelo-Branco
Luis Castelo-Branco
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios
ESEmad Salman Shaikh
Emad Salman Shaikh
EKElif Uygur Kucukseymen
Elif Uygur Kucukseymen
Felipe FregniFelipe Fregni
Felipe Fregni
Fibromyalgia is a complex pain condition that affects mostly women. Given the disease's lack of understanding, patients report poor adherence to medication and mistrust of medical services. This study aims to describe the recruitment characteristics and non-adherence associated factors of fibromyalgia patients to an RCT. We performed a retrospective longitudinal analysis with data from our ongoing RCT. We investigated characteristics of subjects recruited, consented, and randomized. Adherence was studied using survival analysis techniques, and its associated factors were identified using Cox proportional hazards regression model. 524 subjects were contacted, 269 were eligible, 61 consented and 40 subjects were randomized. Thirty-eight percent were non-adherent to the protocol with a median of visits of five. The recruitment survey reported that 90% would likely participate in RCTs, 52% had previous participation, and 19% were aware of RCTs by their physicians. Some barriers were investigator-related (staff's friendliness and receiving the results of their trial participation) and center-related (privacy-confidentiality issues and the institution's reputation), without difference between adherent and non-adherent participants. We report significant factors for non-adherence as VAS anxiety score of 5 or more (5.3 HR, p = 0.01), Body Mass Index (BMI) (0.91 HR, p = 0.041) and Quality of Life (QoL) – Personal development subdomain (0.89 HR, p = 0.046). Recruitment and adherence of fibromyalgia patients is a challenge; however, they seem eager to participate in RCTs. We recommend creating a comfortable, friendly and trusting environment to increase the recruitment rate. Higher anxiety, lower BMI and lower quality of life were associated with a higher attrition rate.

1 July 2021 in Heliyon
Verified
Journal Article
Open access
ACAlejandra Cardenas
Alejandra Cardenas
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios
LCLuis Castelo-Branco
Luis Castelo-Branco
SGStefano Giannoni-Luza
Stefano Giannoni-Luza
ABAna Balbuena-Pareja
Ana Balbuena-Pareja
Felipe FregniFelipe Fregni
Felipe Fregni
There is a need of well-powered randomized clinical trials in fibromyalgia. However, challenges for recruitment are presented. This study aims to describe and assess the perception of barriers and facilitators and the associated factors for the participation of underrepresented and non-underrepresented fibromyalgia patients. We performed an online survey through REDCap (Research Electronic Data Capture) targeting fibromyalgia patients from April 7 to July 3, 2020 during the COVID-19 stay home mandate and it was restricted to the United States of America. We described and compared the survey characteristics between underrepresented and non-underrepresented participants, and we performed logistic regression models to assess the associated factors with clinical trial participation. In total, 481 completed the survey including 168 underrepresented fibromyalgia patients. Only (1) 11.09 % reported previous participation in clinical trials and the significant perceived barriers were investigator-related (lack of friendliness of research staff and the opportunity to receive the results) and center-related (privacy and confidentiality policies, and the institution's reputation); (2) the participation rate and perceived barriers and facilitators were similar between underrepresented and non-underrepresented patients; and was positively associated with low income, higher age, and clinical trial awareness from their physician; and negatively associated with the perception of investigator-related barriers; and (4) for the underrepresented population, the presence of emotional support. Our findings suggest low rates of participation, regardless of underrepresented population status. Strategies as involving their physician as liaison to increase the awareness of clinical trials, as well as improving patient-researcher communication should be considered in this population.

21 September 2021
Verified
Book Chapter
Closed access
PDF file
ENEster Miyuki Nakamura-Palacios
Ester Miyuki Nakamura-Palacios
CRChristiane Furlan Ronchete
Christiane Furlan Ronchete
LFLuna Vasconcelos Felippe
Luna Vasconcelos Felippe
LFLeonardo Villaverde Buback Ferreira
Leonardo Villaverde Buback Ferreira
QAQuézia Silva Anders
Quézia Silva Anders
LRLivia Carla de Melo Rodrigues
Livia Carla de Melo Rodrigues